Jody Corey-Bloom - Publications

Affiliations: 
University of California, San Diego, La Jolla, CA 
Area:
Dementia, MS, Huntington Disease

127 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any innacuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Gilbert PE, Delis DC. New Intrusion Analyses on the CVLT-3: Utility in Distinguishing the Memory Disorders of Alzheimer's versus Huntington's Disease. Journal of the International Neuropsychological Society : Jins. 1-6. PMID 31060638 DOI: 10.1017/S1355617719000407  0.56
2019 Graves LV, Simone S, Williams M, Courville T, Mattson SN, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE. Revisiting total recognition discriminability in Huntington's and Alzheimer's disease: New insights from the CVLT-3. Applied Neuropsychology. Adult. 1-8. PMID 31060389 DOI: 10.1080/23279095.2019.1605993  0.56
2018 Graves LV, Holden HM, Van Etten EJ, Delano-Wood L, Bondi MW, Salmon DP, Corey-Bloom J, Delis DC, Gilbert PE. New Yes/No Recognition Memory Analysis on the California Verbal Learning Test-3: Clinical Utility in Alzheimer's and Huntington's Disease. Journal of the International Neuropsychological Society : Jins. 1-9. PMID 30113280 DOI: 10.1017/S1355617718000474  0.56
2017 Graves LV, Van Etten EJ, Holden HM, Delano-Wood L, Bondi MW, Corey-Bloom J, Delis DC, Gilbert PE. Refining CVLT-II recognition discriminability indices to enhance the characterization of recognition memory changes in healthy aging. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology and Cognition. 1-16. PMID 28857679 DOI: 10.1080/13825585.2017.1372358  0.36
2016 Graves LV, Holden HM, Delano-Wood L, Bondi MW, Woods SP, Corey-Bloom J, Salmon DP, Delis DC, Gilbert PE. Total recognition discriminability in Huntington's and Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 1-11. PMID 27441951 DOI: 10.1080/13803395.2016.1204993  0.56
2016 Corey-Bloom J, Gluhm S, Herndon A, Haque AS, Park S, Gilbert PE. Benton Judgment of Line Orientation (JoLO) Test: A Brief and Useful Measure for Assessing Visuospatial Abilities in Manifest, but not Premanifest, Huntington's Disease. Journal of Huntington's Disease. PMID 27003664 DOI: 10.3233/JHD-150175  0.64
2015 Angus D, Herd C, Stone C, Stout J, Wieler M, Reilmann R, Ritchie CW, Dorsey ER, Helles K, Kayson E, Oakes D, Rosas HD, Vaughan C, Panegyres PK, Ames D, ... ... Corey-Bloom J, et al. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: A phase 2, randomised, double-blind, placebo-controlled trial The Lancet Neurology. 14: 39-47. PMID 25467848 DOI: 10.1016/S1474-4422(14)70262-5  0.64
2015 Pirogovsky E, Nicoll DR, Challener DM, Breen E, Gluhm S, Corey-Bloom J, Gilbert PE. The Visual Spatial Learning Test: differential impairment during the premanifest and manifest stages of Huntington's disease. Journal of Neuropsychology. 9: 77-86. PMID 24330469 DOI: 10.1111/jnp.12036  0.64
2014 Corey-Bloom J, Jia H, Aikin AM, Thomas EA. Disease Modifying Potential of Glatiramer Acetate in Huntington's Disease. Journal of Huntington's Disease. 3: 311-6. PMID 25300334 DOI: 10.3233/JHD-140110  0.64
2014 Du J, Sheth V, He Q, Carl M, Chen J, Corey-Bloom J, Bydder GM. Measurement of T1 of the ultrashort T2* components in white matter of the brain at 3T. Plos One. 9: e103296. PMID 25093859 DOI: 10.1371/journal.pone.0103296  0.64
2014 Hall CA, Reynolds CF, Butters M, Zisook S, Simon N, Corey-Bloom J, Lebowitz BD, Begley A, Mauro C, Shear MK. Cognitive functioning in complicated grief. Journal of Psychiatric Research. 58: 20-5. PMID 25088285 DOI: 10.1016/j.jpsychires.2014.07.002  0.64
2014 Neikrug AB, Avanzino JA, Liu L, Maglione JE, Natarajan L, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Parkinson's disease and REM sleep behavior disorder result in increased non-motor symptoms. Sleep Medicine. 15: 959-66. PMID 24938585 DOI: 10.1016/j.sleep.2014.04.009  0.64
2014 Neikrug AB, Liu L, Avanzino JA, Maglione JE, Natarajan L, Bradley L, Maugeri A, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Continuous positive airway pressure improves sleep and daytime sleepiness in patients with Parkinson disease and sleep apnea. Sleep. 37: 177-85. PMID 24470706 DOI: 10.5665/sleep.3332  0.64
2014 Nicoll DR, Pirogovsky E, Woods SP, Holden HM, Filoteo JV, Gluhm S, Corey-Bloom J, Gilbert PE. "Forgetting to remember" in Huntington's disease: a study of laboratory, semi-naturalistic, and self-perceptions of prospective memory. Journal of the International Neuropsychological Society : Jins. 20: 192-9. PMID 24351166 DOI: 10.1017/S1355617713001355  0.64
2014 Du J, Ma G, Li S, Carl M, Szeverenyi NM, VandenBerg S, Corey-Bloom J, Bydder GM. Ultrashort echo time (UTE) magnetic resonance imaging of the short T2 components in white matter of the brain using a clinical 3T scanner. Neuroimage. 87: 32-41. PMID 24188809 DOI: 10.1016/j.neuroimage.2013.10.053  0.64
2014 Goble DJ, Cone BL, Thurman J, Corey-Bloom J. Balance Declines may Predict Relapse Onset in Multiple Sclerosis-A Case Study Journal of Developmental and Physical Disabilities. 26: 145-150. DOI: 10.1007/s10882-013-9350-4  0.64
2013 Medina LD, Pirogovsky E, Salomonczyk D, Goldstein J, Panzera R, Gluhm S, Simmons R, Corey-Bloom J, Gilbert PE. Postural limits of stability in premanifest and manifest Huntington's disease. Journal of Huntington's Disease. 2: 177-84. PMID 25063514 DOI: 10.3233/JHD-130048  0.64
2013 Nicoll DR, Pirogovsky E, Collazo AE, Tierney SM, Corey-Bloom J, Gilbert PE. The effect of interference on temporal order memory in premanifest and manifest Huntington's disease. Journal of Huntington's Disease. 2: 297-304. PMID 25062677 DOI: 10.3233/JHD-130064  0.64
2013 Van Liew C, Gluhm S, Goldstein J, Cronan TA, Corey-Bloom J. The functional implications of motor, cognitive, psychiatric, and social problem-solving states in Huntington's disease. Psychiatry. 76: 323-35. PMID 24299091 DOI: 10.1521/psyc.2013.76.4.323  0.64
2013 Neikrug AB, Maglione JE, Liu L, Natarajan L, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Effects of sleep disorders on the non-motor symptoms of Parkinson disease. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 9: 1119-29. PMID 24235892 DOI: 10.5664/jcsm.3148  0.64
2013 Majid DS, Cai W, Corey-Bloom J, Aron AR. Proactive selective response suppression is implemented via the basal ganglia. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 13259-69. PMID 23946385 DOI: 10.1523/JNEUROSCI.5651-12.2013  0.64
2013 Maglione JE, Liu L, Neikrug AB, Poon T, Natarajan L, Calderon J, Avanzino JA, Corey-Bloom J, Palmer BW, Loredo JS, Ancoli-Israel S. Actigraphy for the assessment of sleep measures in Parkinson's disease. Sleep. 36: 1209-17. PMID 23904681 DOI: 10.5665/sleep.2888  0.64
2013 Gluhm S, Goldstein J, Brown D, Van Liew C, Gilbert PE, Corey-Bloom J. Usefulness of the Montreal Cognitive Assessment (MoCA) in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28: 1744-7. PMID 23798501 DOI: 10.1002/mds.25578  0.64
2013 Gluhm S, Goldstein J, Loc K, Colt A, Liew CV, Corey-Bloom J. Cognitive performance on the mini-mental state examination and the montreal cognitive assessment across the healthy adult lifespan. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 26: 1-5. PMID 23538566 DOI: 10.1097/WNN.0b013e31828b7d26  0.64
2013 Mickes L, Wixted JT, Peavy GM, Jacobson MW, Goldstein JL, Corey-Bloom J. Difficulty modifying a sustained motor response in prodromal Huntington's disease. Journal of Clinical and Experimental Neuropsychology. 35: 35-40. PMID 23198997 DOI: 10.1080/13803395.2012.742039  0.64
2013 Sherzai A, Edland SD, Masliah E, Hansen L, Pizzo DP, Sherzai A, Corey-Bloom J. Spongiform change in dementia with Lewy bodies and Alzheimer disease. Alzheimer Disease and Associated Disorders. 27: 157-61. PMID 22546782 DOI: 10.1097/WAD.0b013e318256d507  0.64
2012 Covassin N, Neikrug AB, Liu L, Maglione J, Natarajan L, Corey-Bloom J, Loredo JS, Palmer BW, Redwine LS, Ancoli-Israel S. Relationships between clinical characteristics and nocturnal cardiac autonomic activity in Parkinson's disease. Autonomic Neuroscience : Basic & Clinical. 171: 85-8. PMID 23141523 DOI: 10.1016/j.autneu.2012.10.003  0.64
2012 Cloud LJ, Rosenblatt A, Margolis RL, Ross CA, Pillai JA, Corey-Bloom J, Tully HM, Bird T, Panegyres PK, Nichter CA, Higgins DS, Helmers SL, Factor SA, Jones R, Testa CM. Seizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1797-800. PMID 23124580 DOI: 10.1002/mds.25237  0.64
2012 Lessig S, Nie D, Xu R, Corey-Bloom J. Changes on brief cognitive instruments over time in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1125-8. PMID 22692724 DOI: 10.1002/mds.25070  0.64
2012 Pillai JA, Hansen LA, Masliah E, Goldstein JL, Edland SD, Corey-Bloom J. Clinical severity of Huntington's disease does not always correlate with neuropathologic stage. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 1099-103. PMID 22674458 DOI: 10.1002/mds.25026  0.64
2012 Corey-Bloom J, Wolfson T, Gamst A, Jin S, Marcotte TD, Bentley H, Gouaux B. Smoked cannabis for spasticity in multiple sclerosis: a randomized, placebo-controlled trial. Cmaj : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne. 184: 1143-50. PMID 22586334 DOI: 10.1503/cmaj.110837  0.64
2012 Covassin N, Neikrug AB, Liu L, Corey-Bloom J, Loredo JS, Palmer BW, Maglione J, Ancoli-Israel S. Clinical correlates of periodic limb movements in sleep in Parkinson's disease. Journal of the Neurological Sciences. 316: 131-6. PMID 22277375 DOI: 10.1016/j.jns.2012.01.004  0.64
2012 Seibert TM, Majid DS, Aron AR, Corey-Bloom J, Brewer JB. Stability of resting fMRI interregional correlations analyzed in subject-native space: a one-year longitudinal study in healthy adults and premanifest Huntington's disease. Neuroimage. 59: 2452-63. PMID 21945695 DOI: 10.1016/j.neuroimage.2011.08.105  0.64
2012 Corey-Bloom J. Treatment trials in aging and mild cognitive impairment. Current Topics in Behavioral Neurosciences. 10: 347-56. PMID 21786037 DOI: 10.1007/7854_2011_153  0.64
2011 Majid DS, Aron AR, Thompson W, Sheldon S, Hamza S, Stoffers D, Holland D, Goldstein J, Corey-Bloom J, Dale AM. Basal ganglia atrophy in prodromal Huntington's disease is detectable over one year using automated segmentation. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 2544-51. PMID 21932302 DOI: 10.1002/mds.23912  0.64
2011 Turner TH, Goldstein J, Hamilton JM, Jacobson M, Pirogovsky E, Peavy G, Corey-Bloom J. Behavioral measures of saccade latency and inhibition in manifest and premanifest Huntington's disease. Journal of Motor Behavior. 43: 295-302. PMID 21774606 DOI: 10.1080/00222895.2011.580390  0.64
2011 Majid DS, Stoffers D, Sheldon S, Hamza S, Thompson WK, Goldstein J, Corey-Bloom J, Aron AR. Automated structural imaging analysis detects premanifest Huntington's disease neurodegeneration within 1 year. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1481-8. PMID 21484871 DOI: 10.1002/mds.23656  0.64
2011 Panzera R, Salomonczyk D, Pirogovosky E, Simmons R, Goldstein J, Corey-Bloom J, Gilbert PE. Postural deficits in Huntington's disease when performing motor skills involved in daily living. Gait & Posture. 33: 457-61. PMID 21256027 DOI: 10.1016/j.gaitpost.2010.12.025  0.64
2011 Rizk-Jackson A, Stoffers D, Sheldon S, Kuperman J, Dale A, Goldstein J, Corey-Bloom J, Poldrack RA, Aron AR. Evaluating imaging biomarkers for neurodegeneration in pre-symptomatic Huntington's disease using machine learning techniques. Neuroimage. 56: 788-96. PMID 20451620 DOI: 10.1016/j.neuroimage.2010.04.273  0.64
2010 Salomonczyk D, Panzera R, Pirogovosky E, Goldstein J, Corey-Bloom J, Simmons R, Gilbert PE. Impaired postural stability as a marker of premanifest Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2428-33. PMID 20818666 DOI: 10.1002/mds.23309  0.64
2010 Mickes L, Jacobson M, Peavy G, Wixted JT, Lessig S, Goldstein JL, Corey-Bloom J. A comparison of two brief screening measures of cognitive impairment in Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2229-33. PMID 20721924 DOI: 10.1002/mds.23181  0.64
2010 Peavy GM, Jacobson MW, Goldstein JL, Hamilton JM, Kane A, Gamst AC, Lessig SL, Lee JC, Corey-Bloom J. Cognitive and functional decline in Huntington's disease: dementia criteria revisited. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1163-9. PMID 20629124 DOI: 10.1002/mds.22953  0.64
2010 Stoffers D, Sheldon S, Kuperman JM, Goldstein J, Corey-Bloom J, Aron AR. Contrasting gray and white matter changes in preclinical Huntington disease: an MRI study. Neurology. 74: 1208-16. PMID 20385893 DOI: 10.1212/WNL.0b013e3181d8c20a  0.64
2010 Kieburtz K, McDermott MP, Voss TS, Corey-Bloom J, Deuel LM, Dorsey ER, Factor S, Geschwind MD, Hodgeman K, Kayson E, Noonberg S, Pourfar M, Rabinowitz K, Ravina B, Sanchez-Ramos J, et al. A randomized, placebo-controlled trial of latrepirdine in Huntington disease. Archives of Neurology. 67: 154-60. PMID 20142523 DOI: 10.1001/archneurol.2009.334  0.64
2009 Cooke JR, Ayalon L, Palmer BW, Loredo JS, Corey-Bloom J, Natarajan L, Liu L, Ancoli-Israel S. Sustained use of CPAP slows deterioration of cognition, sleep, and mood in patients with Alzheimer's disease and obstructive sleep apnea: a preliminary study. Journal of Clinical Sleep Medicine : Jcsm : Official Publication of the American Academy of Sleep Medicine. 5: 305-9. PMID 19968005  0.64
2009 Cooke JR, Ancoli-Israel S, Liu L, Loredo JS, Natarajan L, Palmer BS, He F, Corey-Bloom J. Continuous positive airway pressure deepens sleep in patients with Alzheimer's disease and obstructive sleep apnea. Sleep Medicine. 10: 1101-6. PMID 19699148 DOI: 10.1016/j.sleep.2008.12.016  0.64
2009 Pirogovsky E, Goldstein J, Peavy G, Jacobson MW, Corey-Bloom J, Gilbert PE. Temporal order memory deficits prior to clinical diagnosis in Huntington's disease. Journal of the International Neuropsychological Society : Jins. 15: 662-70. PMID 19635179 DOI: 10.1017/S1355617709990427  0.64
2009 Jak AJ, Urban S, McCauley A, Bangen KJ, Delano-Wood L, Corey-Bloom J, Bondi MW. Profile of hippocampal volumes and stroke risk varies by neuropsychological definition of mild cognitive impairment. Journal of the International Neuropsychological Society : Jins. 15: 890-7. PMID 19570306 DOI: 10.1017/S1355617709090638  0.64
2009 Jak AJ, Bangen KJ, Wierenga CE, Delano-Wood L, Corey-Bloom J, Bondi MW. Contributions of neuropsychology and neuroimaging to understanding clinical subtypes of mild cognitive impairment. International Review of Neurobiology. 84: 81-103. PMID 19501714 DOI: 10.1016/S0074-7742(09)00405-X  0.64
2009 Jak AJ, Bondi MW, Delano-Wood L, Wierenga C, Corey-Bloom J, Salmon DP, Delis DC. Quantification of five neuropsychological approaches to defining mild cognitive impairment. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 17: 368-75. PMID 19390294 DOI: 10.1097/JGP.0b013e31819431d5  0.64
2009 Khachaturian ZS, Snyder PJ, Doody R, Aisen P, Comer M, Dwyer J, Frank RA, Holzapfel A, Khachaturian AS, Korczyn AD, Roses A, Simpkins JW, Schneider LS, Albert MS, Egge R, ... ... Corey-Bloom JP, et al. A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 5: 85-92. PMID 19328434 DOI: 10.1016/j.jalz.2009.01.021  0.64
2009 Gehrman PR, Connor DJ, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 17: 166-9. PMID 19155748 DOI: 10.1097/JGP.0b013e318187de18  0.64
2008 Ancoli-Israel S, Palmer BW, Cooke JR, Corey-Bloom J, Fiorentino L, Natarajan L, Liu L, Ayalon L, He F, Loredo JS. Cognitive effects of treating obstructive sleep apnea in Alzheimer's disease: a randomized controlled study. Journal of the American Geriatrics Society. 56: 2076-81. PMID 18795985 DOI: 10.1111/j.1532-5415.2008.01934.x  0.64
2008 Marcotte TD, Rosenthal TJ, Roberts E, Lampinen S, Scott JC, Allen RW, Corey-Bloom J. The contribution of cognition and spasticity to driving performance in multiple sclerosis. Archives of Physical Medicine and Rehabilitation. 89: 1753-8. PMID 18760160 DOI: 10.1016/j.apmr.2007.12.049  0.64
2008 Khachaturian ZS, Petersen RC, Gauthier S, Buckholtz N, Corey-Bloom JP, Evans B, Fillit H, Foster N, Greenberg B, Grundman M, Sano M, Simpkins J, Schneider LS, Weiner MW, Galasko D, et al. A roadmap for the prevention of dementia: the inaugural Leon Thal Symposium. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 4: 156-63. PMID 18631960 DOI: 10.1016/j.jalz.2008.03.005  0.64
2008 Fine EM, Delis DC, Wetter SR, Jacobson MW, Hamilton JM, Peavy G, Goldstein J, McDonald C, Corey-Bloom J, Bondi MW, Salmon DP. Identifying the "source" of recognition memory deficits in patients with Huntington's disease or Alzheimer's disease: evidence from the CVLT-II. Journal of Clinical and Experimental Neuropsychology. 30: 463-70. PMID 18415887 DOI: 10.1080/13803390701531912  0.64
2008 Doody RS, Corey-Bloom J, Zhang R, Li H, Ieni J, Schindler R. Safety and tolerability of donepezil at doses up to 20 mg/day: results from a pilot study in patients with Alzheimer's disease. Drugs & Aging. 25: 163-74. PMID 18257603  0.64
2007 Langbehn DR, Paulsen JS. Predictors of diagnosis in Huntington disease. Neurology. 68: 1710-7. PMID 17502553 DOI: 10.1212/01.wnl.0000261918.90053.96  0.64
2007 Pirogovsky E, Gilbert PE, Jacobson M, Peavy G, Wetter S, Goldstein J, Corey-Bloom J, Murphy C. Impairments in source memory for olfactory and visual stimuli in preclinical and clinical stages of Huntington's disease. Journal of Clinical and Experimental Neuropsychology. 29: 395-404. PMID 17497563 DOI: 10.1080/13803390600726829  0.64
2007 Jak AJ, Houston WS, Nagel BJ, Corey-Bloom J, Bondi MW. Differential cross-sectional and longitudinal impact of APOE genotype on hippocampal volumes in nondemented older adults. Dementia and Geriatric Cognitive Disorders. 23: 382-9. PMID 17389798 DOI: 10.1159/000101340  0.64
2007 Yaari R, Corey-Bloom J. Alzheimer's disease. Seminars in Neurology. 27: 32-41. PMID 17226739 DOI: 10.1055/s-2006-956753  0.64
2007 Han SD, Houston WS, Jak AJ, Eyler LT, Nagel BJ, Fleisher AS, Brown GG, Corey-Bloom J, Salmon DP, Thal LJ, Bondi MW. Verbal paired-associate learning by APOE genotype in non-demented older adults: fMRI evidence of a right hemispheric compensatory response. Neurobiology of Aging. 28: 238-47. PMID 16434125 DOI: 10.1016/j.neurobiolaging.2005.12.013  0.64
2007 Corey-Bloom J. Patient management problem Continuum Lifelong Learning in Neurology. 13: 246-255. DOI: 10.1212/01.CON.0000267247.24531.45  0.64
2007 Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC. Appendix B: Practice parameter: Diagnosis of dementia (an evidence-based review): Report of the quality standards subcommittee of the American academy neurology Continuum Lifelong Learning in Neurology. 13: 210-221. DOI: 10.1212/01.CON.0000267232.84626.41  0.64
2007 Corey-Bloom J. Dementia Seminars in Neurology. 27: 3-4. DOI: 10.1055/s-2006-957178  0.64
2007 Corey-Bloom J, Roos KL. Introduction to guest editor Seminars in Neurology. 27: 1. DOI: 10.1055/s-2006-957177  0.64
2006 Cooke JR, Liu L, Natarajan L, He F, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Greenfield D, Ancoli-Israel S. The effect of sleep-disordered breathing on stages of sleep in patients with Alzheimer's disease. Behavioral Sleep Medicine. 4: 219-27. PMID 17083302 DOI: 10.1207/s15402010bsm0404_2  0.64
2006 Cooke JR, Loredo JS, Liu L, Marler M, Corey-Bloom J, Fiorentino L, Harrison T, Ancoli-Israel S. Acetylcholinesterase inhibitors and sleep architecture in patients with Alzheimer's disease. Drugs & Aging. 23: 503-11. PMID 16872233 DOI: 10.2165/00002512-200623060-00005  0.64
2006 Chong MS, Ayalon L, Marler M, Loredo JS, Corey-Bloom J, Palmer BW, Liu L, Ancoli-Israel S. Continuous positive airway pressure reduces subjective daytime sleepiness in patients with mild to moderate Alzheimer's disease with sleep disordered breathing. Journal of the American Geriatrics Society. 54: 777-81. PMID 16696743 DOI: 10.1111/j.1532-5415.2006.00694.x  0.64
2006 Ayalon L, Ancoli-Israel S, Stepnowsky C, Marler M, Palmer BW, Liu L, Loredo JS, Corey-Bloom J, Greenfield D, Cooke J. Adherence to continuous positive airway pressure treatment in patients with Alzheimer's disease and obstructive sleep apnea. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 176-80. PMID 16473983 DOI: 10.1097/01.JGP.0000192484.12684.cd  0.64
2006 Tiraboschi P, Salmon DP, Hansen LA, Hofstetter RC, Thal LJ, Corey-Bloom J. What best differentiates Lewy body from Alzheimer's disease in early-stage dementia? Brain : a Journal of Neurology. 129: 729-35. PMID 16401618 DOI: 10.1093/brain/awh725  0.64
2006 Corey-Bloom J, Yaari R, Weisman D. Managing patients with Alzheimer's disease Practical Neurology. 6: 78-89. DOI: 10.1136/jnnp.2006.088757  0.64
2005 Polich J, Corey-Bloom J. Alzheimer's disease and P300: review and evaluation of task and modality. Current Alzheimer Research. 2: 515-25. PMID 16375655  0.64
2005 Delis DC, Wetter SR, Jacobson MW, Peavy G, Hamilton J, Gongvatana A, Kramer JH, Bondi MW, Corey-Bloom J, Salmon DP. Recall discriminability: utility of a new CVLT-II measure in the differential diagnosis of dementia. Journal of the International Neuropsychological Society : Jins. 11: 708-15. PMID 16248906 DOI: 10.1017/S1355617705050812  0.64
2005 Brodaty H, Corey-Bloom J, Potocnik FC, Truyen L, Gold M, Damaraju CR. Galantamine prolonged-release formulation in the treatment of mild to moderate Alzheimer's disease. Dementia and Geriatric Cognitive Disorders. 20: 120-32. PMID 15990426 DOI: 10.1159/000086613  0.64
2005 Lineweaver TT, Salmon DP, Bondi MW, Corey-Bloom J. Differential effects of Alzheimer's disease and Huntington's disease on the performance of mental rotation. Journal of the International Neuropsychological Society : Jins. 11: 30-9. PMID 15686606 DOI: 10.1017/S1355617705050034  0.64
2005 Hogarth P, Kayson E, Kieburtz K, Marder K, Oakes D, Rosas D, Shoulson I, Wexler NS, Young AB, Zhao H. Interrater agreement in the assessment of motor manifestations of Huntington's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 293-7. PMID 15584032 DOI: 10.1002/mds.20332  0.64
2004 Gehrman P, Marler M, Martin JL, Shochat T, Corey-Bloom J, Ancoli-Israel S. The timing of activity rhythms in patients with dementia is related to survival. The Journals of Gerontology. Series a, Biological Sciences and Medical Sciences. 59: 1050-5. PMID 15528777  0.64
2004 Fennema-Notestine C, Archibald SL, Jacobson MW, Corey-Bloom J, Paulsen JS, Peavy GM, Gamst AC, Hamilton JM, Salmon DP, Jernigan TL. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology. 63: 989-95. PMID 15452288  0.64
2004 Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. The importance of neuritic plaques and tangles to the development and evolution of AD. Neurology. 62: 1984-9. PMID 15184601  0.64
2004 Tiraboschi P, Hansen LA, Masliah E, Alford M, Thal LJ, Corey-Bloom J. Impact of APOE genotype on neuropathologic and neurochemical markers of Alzheimer disease. Neurology. 62: 1977-83. PMID 15184600  0.64
2004 Tiraboschi P, Sabbagh MN, Hansen LA, Salmon DP, Merdes A, Gamst A, Masliah E, Alford M, Thal LJ, Corey-Bloom J. Alzheimer disease without neocortical neurofibrillary tangles: "a second look". Neurology. 62: 1141-7. PMID 15079014  0.64
2004 Hamilton JM, Wolfson T, Peavy GM, Jacobson MW, Corey-Bloom J. Rate and correlates of weight change in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 75: 209-12. PMID 14742590 DOI: 10.1136/jnnp.2003.017822  0.64
2004 Jellinger KA. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 62: 160; author reply 16. PMID 14718731  0.64
2004 Grossberg GT, Corey-Bloom J, Small GW, Tariot PN. Emerging therapeutic strategies in Alzheimer's disease Journal of Clinical Psychiatry. 65: 255. DOI: 10.4088/JCP.v65n0218  0.64
2003 Ancoli-Israel S, Gehrman P, Martin JL, Shochat T, Marler M, Corey-Bloom J, Levi L. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer's disease patients. Behavioral Sleep Medicine. 1: 22-36. PMID 15600135 DOI: 10.1207/S15402010BSM0101_4  0.64
2003 Bondi MW, Houston WS, Salmon DP, Corey-Bloom J, Katzman R, Thal LJ, Delis DC. Neuropsychological deficits associated with Alzheimer's disease in the very-old: discrepancies in raw vs. standardized scores. Journal of the International Neuropsychological Society : Jins. 9: 783-95. PMID 12901784 DOI: 10.1017/S1355617703950119  0.64
2003 Gehrman PR, Martin JL, Shochat T, Nolan S, Corey-Bloom J, Ancoli-Israel S. Sleep-disordered breathing and agitation in institutionalized adults with Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 11: 426-33. PMID 12837671 DOI: 10.1097/00019442-200307000-00005  0.64
2003 Merdes AR, Hansen LA, Jeste DV, Galasko D, Hofstetter CR, Ho GJ, Thal LJ, Corey-Bloom J. Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology. 60: 1586-90. PMID 12771246  0.64
2003 Corey-Bloom J. Galantamine: a review of its use in Alzheimer's disease and vascular dementia. International Journal of Clinical Practice. 57: 219-23. PMID 12723727  0.64
2003 Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I. Predictors of nursing home placement in Huntington disease. Neurology. 60: 998-1001. PMID 12654967  0.64
2003 Ancoli-Israel S, Martin JL, Gehrman P, Shochat T, Corey-Bloom J, Marler M, Nolan S, Levi L. Effect of light on agitation in institutionalized patients with severe Alzheimer disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 11: 194-203. PMID 12611749 DOI: 10.1097/00019442-200303000-00010  0.64
2003 Hamilton JM, Salmon DP, Corey-Bloom J, Gamst A, Paulsen JS, Jerkins S, Jacobson MW, Peavy G. Behavioural abnormalities contribute to functional decline in Huntington's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 74: 120-2. PMID 12486282 DOI: 10.1136/jnnp.74.1.120  0.64
2002 Corey-Bloom J. The ABC of Alzheimer's disease: cognitive changes and their management in Alzheimer's disease and related dementias. International Psychogeriatrics / Ipa. 14: 51-75. PMID 12636180 DOI: 10.1017/S1041610203008664  0.64
2002 Tiraboschi P, Hansen LA, Alford M, Merdes A, Masliah E, Thal LJ, Corey-Bloom J. Early and widespread cholinergic losses differentiate dementia with Lewy bodies from Alzheimer disease. Archives of General Psychiatry. 59: 946-51. PMID 12365882  0.64
2001 Knopman DS, DeKosky ST, Cummings JL, Chui H, Corey-Bloom J, Relkin N, Small GW, Miller B, Stevens JC. Practice parameter: diagnosis of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 56: 1143-53. PMID 11342678  0.64
2001 Corey-Bloom J, Geldmacher DS, Jann MW. Contemporary drug treatment Patient Care. 35: 54-67.  0.64
2000 Tiraboschi P, Hansen LA, Alford M, Masliah E, Thal LJ, Corey-Bloom J. The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease. Neurology. 55: 1278-83. PMID 11087768  0.64
2000 Rei RT, Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thal LJ. Nicotinic receptor losses in dementia with Lewy bodies: comparisons with Alzheimer's disease. Neurobiology of Aging. 21: 741-6. PMID 11016544 DOI: 10.1016/S0197-4580(00)00168-8  0.6
2000 Hohl U, Tiraboschi P, Hansen LA, Thal LJ, Corey-Bloom J. Diagnostic accuracy of dementia with Lewy bodies. Archives of Neurology. 57: 347-51. PMID 10714660  0.64
2000 Tiraboschi P, Hansen LA, Alford M, Sabbagh MN, Schoos B, Masliah E, Thal LJ, Corey-Bloom J. Cholinergic dysfunction in diseases with Lewy bodies. Neurology. 54: 407-11. PMID 10668703  0.64
2000 Corey-Bloom J, Tiraboschi P, Hansen LA, Alford M, Schoos B, Sabbagh MN, Masliah E, Thal LJ. E4 allele dosage does not predict cholinergic activity or synapse loss in Alzheimer's disease. Neurology. 54: 403-6. PMID 10668702  0.64
1999 Sabbagh MN, Corey-Bloom J, Tiraboschi P, Thomas R, Masliah E, Thal LJ. Neurochemical markers do not correlate with cognitive decline in the Lewy body variant of Alzheimer disease. Archives of Neurology. 56: 1458-61. PMID 10593300  0.64
1998 Barrett-Connor E, Edelstein S, Corey-Bloom J, Wiederholt W. Weight loss precedes dementia in community-dwelling older adults. The Journal of Nutrition, Health & Aging. 2: 113-4. PMID 10993579  0.64
1998 Morris SK, Olichney JM, Corey-Bloom J. Psychosis in Dementia With Lewy Bodies. Seminars in Clinical Neuropsychiatry. 3: 51-60. PMID 10085191  0.56
1998 Sabbagh MN, Reid RT, Corey-Bloom J, Rao TS, Hansen LA, Alford M, Masliah E, Adem A, Lloyd GK, Thal LJ. Correlation of nicotinic binding with neurochemical markers in Alzheimer's disease. Journal of Neural Transmission (Vienna, Austria : 1996). 105: 709-17. PMID 9826113 DOI: 10.1007/s007020050090  0.64
1998 Grundman M, Corey-Bloom J, Thal LJ. Perspectives in clinical Alzheimer's disease research and the development of antidementia drugs. Journal of Neural Transmission. Supplementum. 53: 255-75. PMID 9700663  0.64
1998 Corey-Bloom J. Editorial comment Current Therapeutic Research - Clinical and Experimental. 59: 835-836. DOI: 10.1016/S0011-393X(98)85047-9  0.64
1998 Corey-Bloom J, Anand R, Veach J. A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease International Journal of Geriatric Psychopharmacology. 1: 55-65.  0.64
1997 Symonds LL, Olichney JM, Jernigan TL, Corey-Bloom J, Healy JF, Jeste DV. Lack of clinically significant gross structural abnormalities in MRIs of older patients with schizophrenia and related psychoses. The Journal of Neuropsychiatry and Clinical Neurosciences. 9: 251-8. PMID 9144105  0.64
1997 Royall DR, Chiodo LK, Polk MS. Senility redefined as age-associated frontal system impairment? Journal of the American Geriatrics Society. 45: 386-388. PMID 9063294 DOI: 10.1111/j.1532-5415.1997.tb00964.x  0.64
1997 Corey-Bloom J, Sabbagh MN, Bondi MW, Hansen L, Alford MF, Masliah E, Thal LJ. Hippocampal sclerosis contributes to dementia in the elderly. Neurology. 48: 154-60. PMID 9008511  0.64
1996 Cahn DA, Salmon DP, Monsch AU, Butters N, Wiederholt WC, Corey-Bloom J, Barrett-Connor E. Screening for dementia of the alzheimer type in the community: the utility of the Clock Drawing Test. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 11: 529-39. PMID 14588458 DOI: 10.1016/0887-6177(95)00041-0  0.64
1996 Barrett-Connor E, Edelstein SL, Corey-Bloom J, Wiederholt WC. Weight loss precedes dementia in community-dwelling older adults. Journal of the American Geriatrics Society. 44: 1147-52. PMID 8855991  0.64
1996 Grundman M, Corey-Bloom J, Jernigan T, Archibald S, Thal LJ. Low body weight in Alzheimer's disease is associated with mesial temporal cortex atrophy. Neurology. 46: 1585-91. PMID 8649553  0.64
1996 Corey-Bloom J, Wiederholt WC, Edelstein S, Salmon DP, Cahn D, Barrett-Connor E. Cognitive and functional status of the oldest old. Journal of the American Geriatrics Society. 44: 671-4. PMID 8642158  0.64
1995 Cahn DA, Salmon DP, Butters N, Wiederholt WC, Corey-Bloom J, Edelstein SL, Barrett-Connor E. Detection of dementia of the Alzheimer type in a population-based sample: neuropsychological test performance. Journal of the International Neuropsychological Society : Jins. 1: 252-60. PMID 9375219  0.64
1995 Olichney JM, Galasko D, Corey-Bloom J, Thal LJ. The spectrum of diseases with diffuse Lewy bodies. Advances in Neurology. 65: 159-70. PMID 7872137  0.64
1995 Corey-Bloom J, Jernigan T, Archibald S, Harris MJ, Jeste DV. Quantitative magnetic resonance imaging of the brain in late-life schizophrenia. The American Journal of Psychiatry. 152: 447-9. PMID 7864275  0.64
1995 Corey-Bloom J, Thal LJ, Galasko D, Folstein M, Drachman D, Raskind M, Lanska DJ. Diagnosis and evaluation of dementia. Neurology. 45: 211-8. PMID 7854514  0.64
1995 Corey-Bloom J, Galasko D. Adjunctive therapy in patients with Alzheimer's disease. A practical approach. Drugs & Aging. 7: 79-87. PMID 7579786 DOI: 10.2165/00002512-199507020-00002  0.64
1993 Corey-Bloom J, Galasko D, Hofstetter CR, Jackson JE, Thal LJ. Clinical features distinguishing large cohorts with possible AD, probable AD, and mixed dementia. Journal of the American Geriatrics Society. 41: 31-7. PMID 8418119  0.64
1993 Galasko D, Abramson I, Corey-Bloom J, Thal LJ. Repeated exposure to the Mini-Mental State Examination and the Information-Memory-Concentration Test results in a practice effect in Alzheimer's disease. Neurology. 43: 1559-63. PMID 8351011  0.64
1992 Schneider LS. Tracking dementia by the IMC and the MMSE. Journal of the American Geriatrics Society. 40: 537-8. PMID 1634715  0.64
1992 Galasko D, Corey-Bloom J, Thal LJ. In reply Journal of the American Geriatrics Society. 40: 538. DOI: 10.1111/j.1532-5415.1992.tb02031.x  0.64
1991 Chamberlain MC, Corey-Bloom J. Leptomeningeal metastases: 111indium-DTPA CSF flow studies. Neurology. 41: 1765-9. PMID 1944906  0.64
1991 Galasko D, Corey-Bloom J, Thal LJ. Monitoring progression in Alzheimer's disease. Journal of the American Geriatrics Society. 39: 932-41. PMID 1842209  0.64
Show low-probability matches.